Completed PHASE1 INTERVENTIONAL NCT00002801

Combination Chemotherapy and Radiation Therapy in Treating Patients With Colorectal Cancer

PHASE I TRIAL OF POST-OPERATIVE COMBINED ORAL UFT PLUS LEUCOVORIN AND RADIATION THERAPY FOR RECTAL CANCER

Sponsor: Memorial Sloan Kettering Cancer Center

Interventions leucovorin calcium radiation therapy tegafur-uracil

Updated 5 times since 2017 Last updated: Dec 18, 2013 Started: Apr 30, 1996 Primary completion: Dec 31, 2003 Completion: Dec 31, 2009

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT00002801, this PHASE1 trial focuses on Colorectal Cancer and remains completed. Sponsored by Memorial Sloan Kettering Cancer Center, it has been updated 5 times since 1996, reflecting limited change activity. This study contributes to the evolving evidence base for cancer treatment protocols.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE1
Jul 2024 — Sep 2024 [monthly]

Completed PHASE1
Jan 2021 — Jul 2024 [monthly]

Completed PHASE1
Jun 2018 — Jan 2021 [monthly]

Completed PHASE1
Jan 2017 — Jun 2018 [monthly]

Completed PHASE1

First recorded

Apr 1996

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Memorial Sloan Kettering Cancer Center

Data source: National Cancer Institute (NCI)

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• New York, United States